Evidence map›Paper›PMID 32191718›Full record

ArticlePloS one2020

Hounsfield units and fractal dimension (test HUFRA) for determining PET positive/negative lymph nodes in pediatric Hodgkin's lymphoma patients.

Radosław Chaber, Mateusz Łasecki, Karol Kuczyński, Rafał Cebryk, Justyna Kwaśnicka, Cyprian Olchowy, Kornelia Łach, Zbigniew Pogodajny, Olga Koptiuk, Anna Olchowy and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. The Role of CT Angiography to Predict the Shamblin Group in Carotid Body Tumors.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Radosław ChaberClinic of Pediatric Oncology and Hematology; Medical Faculty, University of Rzeszow, Rzeszow, Poland.
Mateusz ŁaseckiMedical University of Wroclaw, Wroclaw, Poland.ORCID 0000-0002-5879-5366
Karol KuczyńskiThe State School of Higher Education in Chełm, Chełm, Poland.
Rafał CebrykInstitute of Computer Science, Maria Curie-Sklodowska University, Lublin, Poland.
Justyna KwaśnickaDepartment of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Wroclaw, Poland.
Cyprian OlchowyDepartment of Oral Surgery, Wrocław Medical University, Wrocław, Poland.
Kornelia ŁachClinic of Pediatric Oncology and Hematology; Medical Faculty, University of Rzeszow, Rzeszow, Poland.
Zbigniew PogodajnyAffidea Center of Positron Emission Tomography and Computed Tomography, Wrocław, Poland.
Olga KoptiukRadiology Department, Lower Silesian Oncology Center in Wrocław, Wrocław, Poland.
Anna OlchowyDepartment of Experimental Dentistry, Wroclaw Medical University, Wroclaw, Poland.
Paweł PopeckiDepartament of Dental Surgery, Wroclaw Medical University, Wroclaw, Poland.
Urszula Zaleska-DorobiszDepartment of Radiology, Medical University of Wroclaw, Wroclaw, Poland.
Wroclaw Medical University · PLUniversity of Rzeszów · PLUniversity of Wrocław · PLLublin Oncology Center · PLMaria Curie-Skłodowska University · PLState School of Higher Education in Chełm · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe had developed a method that can help detect and identify lymph nodes affected by the neoplastic process. Our group evaluated the fractal dimension (FD) and X-ray attenuation (XRA) of lymph nodes in HL and compared to their metabolic activity as measured by 18F-FDG-PET examination.

methodsThe training set included 72 lymph nodes from 31 consecutive patients, and the tested set of 71 lymph nodes from next 19 patients. The measurement of FD of each lymph node was performed before the start of therapy using original software. X-ray attenuation (XRA) expressed in HU (Hounsfield Units) from CT scans was compared with the metabolic activity of the lymphatic nodes, measured by 18F-FDG-PET examination.

resultsSignificant differences were observed between XRAmax and FDmax values in assessing the PET(+) and PET(-) nodes. All nodes were scored from 0 to 2. The HUFRA test properly qualified 95% with a score of 2 and 0 points as PET(+) or PET(-).

conclusionThe HUFRA test can differentiate about 70-80% of lymph nodes as PET(+) or PET(-) based solely on the CT examination. It can be useful in patients who were not subjected to 18FFDG-PET/CT examination before the treatment, or who had an unreliable result of 18F-FDG-PET/CT with further research requirements.

Indexed as

Positron-Emission TomographyAdolescentChildFemaleFluorodeoxyglucose F18FractalsHodgkin DiseaseHumansLymphatic MetastasisLymph NodesMaleRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID32191718
PMCPMC7082024
OpenAlexW3012100632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.